{"id":2890,"date":"2017-01-10T15:50:00","date_gmt":"2017-01-10T17:50:00","guid":{"rendered":"https:\/\/revistaabcd.org.br\/?p=2890"},"modified":"2022-06-09T15:56:27","modified_gmt":"2022-06-09T18:56:27","slug":"angiolymphatic-invasion-as-a-prognostic-fator-in-resected-n0-pancreatic-adenocarcinoma","status":"publish","type":"post","link":"https:\/\/revistaabcd.org.br\/pt-br\/angiolymphatic-invasion-as-a-prognostic-fator-in-resected-n0-pancreatic-adenocarcinoma\/","title":{"rendered":"Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma"},"content":{"rendered":"
Pancreatic adenocarcinoma remains one of the worst digestive cancers. Surgical resection is the main target when treating a patient with curative intent.<\/p>\n\n\n\n
To assess angiolymphatic invasion as a prognostic factor in resected pN0 pancreatic cancer.<\/p>\n\n\n\n
Thirty-eight patients were submitted to pancreatoduodenectomy due to head pancreatic cancer. Tumor size, margins, lymph nodes, pTNM staging, angiolymphatic and perineural invasion were described in the pathologists' reports.<\/p>\n\n\n\n
Most patients were female. Overall median survival was 13 months. Gemcitabine was the regimen of choice for chemotherapy in selected patients; however, it did not improve overall survival. pR0 resection had better survival compared with pR1. Within the pN0 group, survival was significantly better in patients without angiolymphatic invasion.<\/p>\n\n\n\n
Angiolymphatic invasion in N0 pancreatoduodenectomy can be demonstrated by the Hematoxylin-Eosin stain and may predict a poor prognosis factor for those patients.<\/p>","protected":false},"excerpt":{"rendered":"
Background: Pancreatic adenocarcinoma remains one of the worst digestive cancers. Surgical resection is the main target when treating a patient with curative intent. Aim: To assess angiolymphatic invasion as a prognostic factor in resected pN0 pancreatic cancer. Methods: Thirty-eight patients were submitted to pancreatoduodenectomy due to head pancreatic cancer. Tumor size, margins, lymph nodes, pTNM […]<\/p>","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[9],"tags":[323,790,209],"class_list":["post-2890","post","type-post","status-publish","format-standard","hentry","category-original-article","tag-adenocarcinoma","tag-outcome-assessment","tag-pancreatic-neoplasms"],"acf":[],"modified_by":"Doris","_links":{"self":[{"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/posts\/2890"}],"collection":[{"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/comments?post=2890"}],"version-history":[{"count":0,"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/posts\/2890\/revisions"}],"wp:attachment":[{"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/media?parent=2890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/categories?post=2890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/revistaabcd.org.br\/pt-br\/wp-json\/wp\/v2\/tags?post=2890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}